首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium
【24h】

Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium

机译:分泌IL-1抑制剂的骨骼肌成肌细胞的移植可调节梗死小鼠心肌的不良重塑

获取原文
获取原文并翻译 | 示例
       

摘要

After myocardial infarction (MI), adverse remodeling with left ventricular (LV) dilatation is a major determinant of poor outcome. Skeletal myoblast (SkM) implantation improves cardiac function post-MI, although the mechanism is unclear. IL-1 influences post-MI hypertrophy and collagen turnover and is implicated in SkM death after grafting. We hypothesized that SkM expressing secretory IL-1 receptor antagonist (sIL-1ra) at MI border zones would specifically attenuate adverse remodeling and exhibit improved graft cell number. Stable murine male SkM lines (5 x 105 cells), expressing or nonexpressing (cont) for sIL-1ra, were implanted into infarct border zones of female nude mice immediately after left coronary artery occlusion. LV ejection fraction (LVEF), end-diastolic diameter, and transmitral peak early/late (E/A) flow velocity ratio were determined by echocardiography. Cardiac myocyte hypertrophy and fibrosis were assessed by morphometry, picrosirius red staining, and hydroxyproline assay. At 3 weeks, cont-SkM-engrafted hearts showed reduced hypertrophy, improved LVEF (55.7 +/- 1.2% vs. MI-only: 40.3 +/- 2.9%), and preserved E/A ratios. sIL-1ra-SkM implantation enhanced these effects (LVEF, 67.0 +/- 2.3%) and significantly attenuated LV dilatation (LV end-diastolic diameter, 4.0 +/- 1.1 mm vs. cont-SkM, 4.5 +/- 1.2 mm vs. MI-only, 4.8 +/- 1.8 mm); this was associated with greater graft numbers, as shown by PCR for male-specific smcy gene. Enzyme zymography showed attenuated matrix metalloproteinase-2 and -9 up-regulation post-MI by either donor SkM type, although infarct-remote zone collagen was reduced only with sIL-1ra-SkM. These results suggest that SkM implantation improves cardiac function post-MI by modulation of adverse remodeling, and that this effect can be significantly enhanced by targeting IL-1 as a key upstream regulator of both adverse remodeling and graft cell death. [References: 42]
机译:心肌梗塞(MI)后,左心室(LV)扩张的不良重塑是不良预后的主要决定因素。尽管机制尚不清楚,但骨骼肌成肌细胞(SkM)植入可改善心梗后的心脏功能。 IL-1影响心肌梗死后肥大和胶原蛋白更新,并与嫁接后SkM死亡有关。我们假设,SkM在MI边缘区表达分泌性IL-1受体拮抗剂(sIL-1ra)会特异性地减轻不良重塑并表现出改善的移植细胞数量。表达或不表达(续)sIL-1ra的稳定的鼠雄性SkM系(5 x 105细胞),在左冠状动脉闭塞后立即植入雌性裸鼠的梗塞边界区域。通过超声心动图确定左室射血分数(LVEF),舒张末期直径和经峰峰值早期/晚期(E / A)流速比。通过形态计量学,picrosirius红染色和羟脯氨酸分析评估心肌肥大和纤维化。在第3周,移植了Cont-SkM的心脏显示出肥厚的减少,LVEF的改善(55.7 +/- 1.2%,仅MI的则为40.3 +/- 2.9%),并且E / A率保持不变。 sIL-1ra-SkM植入增强了这些作用(LVEF,67.0 +/- 2.3%),并显着减弱了LV扩张(LV舒张末期直径为4.0 +/- 1.1 mm vs.cont-SkM,4.5 +/- 1.2 mm vs 。仅MI,4.8 +/- 1.8毫米);如男性特异性smcy基因的PCR所示,这与更大的移植物数量有关。酶酶谱显示两种供体SkM类型均降低了MI后基质金属蛋白酶2和-9的上调,尽管仅用sIL-1ra-SkM减少了梗死旁区胶原。这些结果表明,SkM植入可通过调节不良重塑来改善心梗后的心脏功能,并且通过将IL-1靶向作为不良重塑和移植细胞死亡的关键上游调节剂,可以显着增强这种作用。 [参考:42]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号